
Anti-laminin 332 mucous membrane pemphigoid is a rare autoimmune disease that causes severe mucosal lesions resulting in visual impairment, dysphagia, dyspnea, malnutrition, impaired physical function, and decreased activities of daily living. Reports of multidisciplinary treatment for the disease, including rehabilitation, remain scarce. This study presents a case of a 62-year-old Japanese woman complicated by infrequent severe laryngeal lesions and endometrial cancer. The patient experienced recurrent disease exacerbations and hospitalizations, eventually requiring a wheelchair, tube feeding, and a tracheostomy, with no signs of improvement in the deformities of the pharynx and larynx. However, following comprehensive systemic therapies, she could independently engage in activities of daily living and consume a mixed diet with small amounts of solids. Her Barthel Index score improved from 35 to 95, and her weight increased from 29.5 kg to 33.4 kg. Multidisciplinary collaboration across medical departments is essential to maintain and improve physical and swallowing functions in such complex cases.
A man in his late 30s presented with a five-year history of throat discomfort following the discovery of oropharyngeal lesions abroad. Examination revealed multifocal submucosal deposits involving the bilateral peritonsillar regions, posterior oropharyngeal wall, and larynx, including the interarytenoid region. Biopsy demonstrated Congo red–positive amyloid deposition, with liquid chromatography-tandem mass spectrometry confirming AL (lambda)-type amyloid. Systemic evaluation showed no evidence of systemic amyloidosis or underlying plasma cell dyscrasia, supporting a diagnosis of localized AL amyloidosis. Given the multifocal distribution and involvement of surgically high-risk areas, conservative management with continued clinical surveillance was pursued. This case illustrates a rare presentation of multifocal localized AL-type amyloidosis in Waldeyer’s ring and the interarytenoid region. Accurate subtyping and exclusion of systemic disease are essential, and conservative management may be appropriate in select patients with mild symptoms.
Mucoepidermoid carcinoma (MEC) is the most common malignant salivary gland tumor, yet sinonasal MEC is exceedingly rare, comprising less than 0.1% of sinonasal malignancies. We present an 81-year-old man referred for Mohs micrographic surgery of a right nasal tumor initially diagnosed as moderately differentiated squamous cell carcinoma with basaloid differentiation. During Mohs surgery, frozen sections demonstrated glandular structures with mucin pools invading through muscle and cartilage, with perineural invasion, findings discordant with the initial diagnosis. Surgery was halted, and the specimen was submitted for permanent sections. Nasal endoscopy revealed an intranasal mass, and final pathology demonstrated intermediate-grade MEC with cartilaginous and perineural invasion. This case highlights the importance of reassessing the diagnosis when Mohs frozen-section findings are discordant with the initial biopsy, particularly for tumors lacking epidermal connection, and underscores the need to consider non-cutaneous origins and pursue multidisciplinary referral.
Perniosis is characterized by painful acral lesions triggered by cold exposure and lacks reliably effective treatments when refractory. We describe a 56-year-old man with biopsy-confirmed perniosis causing recurrent, debilitating acral pain and lesions despite multiple topical and systemic therapies. Beginning in October 2023, he received annual pre-winter onabotulinumtoxinA (BTX-A; 100 units per extremity pair), injected at interdigital sites of the feet and dorsal digital neurovascular bundles of the hands. Following the initial treatment, pain resolved and lesions cleared within 2 weeks, with protection for 3 months before breakthrough flares emerged as the effect waned. Repeated annual BTX-A, with zinc sulfate initiated before subsequent treatment, achieved sustained seasonal disease control across 3 successive winters, extending into spring after the latest cycle, without adverse effects. This case supports further study of seasonally timed BTX-A as a targeted treatment for refractory perniosis.
Bullous pyoderma gangrenosum (BPG) is the rarest subtype of pyoderma gangrenosum, characterized by painful serous or hemorrhagic bullae that may rapidly ulcerate and progress to necrosis. Approximately 70% of cases are associated with hematologic malignancies, most commonly acute myeloid leukemia, whereas associations with B-cell lymphomas are uncommon. We report an 82-year-old woman who developed hemorrhagic bullae on the upper extremities during hospitalization. Histopathology demonstrated a dense neutrophilic infiltrate with subcorneal blister formation and secondary leukocytoclastic changes, while direct immunofluorescence was negative. After exclusion of infection, systemic vasculitis, and thrombosis, a diagnosis of BPG was established. Subsequent hematologic evaluation prompted by marked leukocytosis, thrombocytopenia, and clonal lymphocytes on flow cytometry revealed low-grade B-cell lymphoma. This rare case of BPG associated with low-grade B-cell lymphoma highlights the diagnostic challenges of this uncommon neutrophilic dermatosis and underscores the importance of evaluating for underlying hematologic malignancy.